Sign Up
OverviewAPI
Anima Biotech's mRNA Lightning Platform demonstrates promising preclinical data for lung fibrosis candidate, showing potential in mitigating fibrotic diseases. Strategic collaborations with big pharma and partnerships with Lilly, Takeda, and AbbVie validate its approach. The company's platform spans various therapeutic areas with a pipeline of 20 drug discovery programs across Immunology, Oncology, and Neuroscience.

Ask a question